Simplex Trading’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-25,538
| Closed | -$981K | – | 10303 |
|
|
2023
Q2 | $981K | Buy |
+25,538
| New | +$656K | ﹤0.01% | 2621 |
|
|
2022
Q2 | – | Sell |
-1,797
| Closed | -$28.2K | – | 11496 |
|
|
2022
Q1 | $29K | Buy |
+1,797
| New | +$24.4K | ﹤0.01% | 7829 |
|
|
2021
Q4 | – | Sell |
-260
| Closed | -$3.7K | – | 11750 |
|
|
2021
Q3 | $3K | Hold |
260
| – | – | ﹤0.01% | 9478 |
|
|
2021
Q2 | $3K | Buy |
+260
| New | +$4.16K | ﹤0.01% | 9665 |
|
|
2020
Q4 | – | Sell |
-529
| Closed | -$7.98K | – | 9305 |
|
|
2020
Q3 | $6K | Sell |
529
-160
| -23% | -$2.14K | ﹤0.01% | 7069 |
|
|
2020
Q2 | $7K | Sell |
689
-313
| -31% | -$4.32K | ﹤0.01% | 6857 |
|
|
2020
Q1 | $13K | Buy |
1,002
+980
| +4,455% | +$11.6K | ﹤0.01% | 6314 |
|
|
2019
Q4 | $0 | Buy |
+22
| New | +$120 | ﹤0.01% | 8186 |
|
|
2019
Q3 | – | Sell |
-318
| Closed | -$2.11K | – | 8081 |
|
|
2019
Q2 | $2K | Buy |
+318
| New | +$4.84K | ﹤0.01% | 6802 |
|
|
2018
Q3 | – | Sell |
-387
| Closed | -$12.4K | – | 8274 |
|
|
2018
Q2 | $13K | Sell |
387
-1,490
| -79% | -$57.1K | ﹤0.01% | 6194 |
|
|
2018
Q1 | $87K | Buy |
1,877
+1,041
| +125% | +$38.1K | ﹤0.01% | 1915 |
|
|
2017
Q4 | $31K | Buy |
+836
| New | +$36.5K | ﹤0.01% | 2902 |
|
|
2017
Q1 | – | Sell |
-232
| Closed | -$13.1K | – | 6967 |
|
|
2016
Q4 | $13K | Buy |
+232
| New | +$14K | ﹤0.01% | 3495 |
|
|
2016
Q3 | – | Sell |
-896
| Closed | -$63.3K | – | 6649 |
|
|
2016
Q2 | $50K | Sell |
896
-1,234
| -58% | -$75K | ﹤0.01% | 2063 |
|
|
2016
Q1 | $136K | Buy |
+2,130
| New | +$172K | 0.01% | 1124 |
|
|
2015
Q4 | – | Sell |
-18
| Closed | -$2.44K | – | 6336 |
|
|
2015
Q3 | $1K | Buy |
18
+11
| +157% | +$1.31K | ﹤0.01% | 5216 |
|
|
2015
Q2 | $1K | Buy |
+7
| New | +$1.16K | ﹤0.01% | 4864 |
|
Simplex Trading's KDNY Position: Q3 2023 in Review
Simplex Trading sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 25,538 shares — an estimated $981K sold.
Simplex Trading first reported a position in KDNY in Q2 2015 and held it in 17 quarters. The position peaked at $981K in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.
- Simplex Trading reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Simplex Trading sold 25,538 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $981K.
- Simplex Trading first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and held it in 17 quarters.
- Simplex Trading's Chinook Therapeutics, Inc. Common Stock position peaked at $981K in Q2 2023.
- 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.
Based on Simplex Trading's 13F filing for Q3 2023, filed 1 Nov 2023.